Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer. 2010 May 1;116(9):2266–2274. doi: 10.1002/cncr.24929

Figure 3.

Figure 3

Figure 3

(a) The 44 patients whose tumors were discrepantly assigned grade 3 on the POG system and grade 1 or 2 on the FNCLCC system had an event-free survival experience that was intermediate between those whose tumors were assigned grade 1/2 or grade 3 on both systems. (b) The analysis remained valid in the subset of patients with non-metastatic disease.